Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig C Earle

Showing results (241-250 of 288) with videos related to

Pageof 29
Sort By:
Digestive Diseases and Sciences|January 18, 2006
A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinomaPeter C Enzinger, Matthew H Kulke, Jeffrey W Clark, et al.
MDM Policy & Practice|July 2, 2021
Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian ProvincesReka E Pataky, Jaclyn Beca, David Tran, et al.
BMC Cancer|April 16, 2020
Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, CanadaWei Fang Dai, Jaclyn M Beca, Ruth Croxford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancerJeffrey A Meyerhardt, Andrew X Zhu, Peter C Enzinger, et al.
Journal of Geriatric Oncology|July 3, 2020
The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, CanadaPhillip S Blanchette, Melody Lam, Britney Le, et al.
JAMA Network Open|November 15, 2021
The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic CancerMichael J Raphael, William Raskin, Steven Habbous, et al.
Breast Cancer Research and Treatment|October 2, 2019
Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, CanadaPhillip S Blanchette, Melody Lam, Lucie Richard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2012
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumorsJennifer A Chan, Keith Stuart, Craig C Earle, et al.
Cancer|January 30, 2002
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinomaDavid P Ryan, Matthew H Kulke, Charles S Fuchs, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|July 19, 2021
Breast Density and Risk of Interval Cancers: The Effect of Annual Versus Biennial Screening Mammography Policies in CanadaJean Morag Seely, Susan Elizabeth Peddle, Huiming Yang, et al.
Pageof 29

Showing results (241-250 of 288) with videos related to

Sort By:
Pageof 29
Digestive Diseases and Sciences|January 18, 2006
A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinomaPeter C Enzinger, Matthew H Kulke, Jeffrey W Clark, et al.
MDM Policy & Practice|July 2, 2021
Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian ProvincesReka E Pataky, Jaclyn Beca, David Tran, et al.
BMC Cancer|April 16, 2020
Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, CanadaWei Fang Dai, Jaclyn M Beca, Ruth Croxford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancerJeffrey A Meyerhardt, Andrew X Zhu, Peter C Enzinger, et al.
Journal of Geriatric Oncology|July 3, 2020
The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, CanadaPhillip S Blanchette, Melody Lam, Britney Le, et al.
JAMA Network Open|November 15, 2021
The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic CancerMichael J Raphael, William Raskin, Steven Habbous, et al.
Breast Cancer Research and Treatment|October 2, 2019
Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, CanadaPhillip S Blanchette, Melody Lam, Lucie Richard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2012
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumorsJennifer A Chan, Keith Stuart, Craig C Earle, et al.
Cancer|January 30, 2002
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinomaDavid P Ryan, Matthew H Kulke, Charles S Fuchs, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|July 19, 2021
Breast Density and Risk of Interval Cancers: The Effect of Annual Versus Biennial Screening Mammography Policies in CanadaJean Morag Seely, Susan Elizabeth Peddle, Huiming Yang, et al.
Pageof 29